Skip to main content

Advertisement

Table 1 Baseline characteristics (n = 75)

From: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Characteristic  
Age (mean ± SD, range) 50.9 ± 11.5, 29.2-77.4
CAGn (mean ± SD, range) 44.5 ± 3.4, 39-54
Women, n (%) 49 (65%)
Caucasian, n (%) 71 (95%)
Affected Parent, n (%)  
   Mother 33 (44%)
   Father 33 (44%)
   Unspecified 9 (12%)
Years of Illness duration (mean ± SD, range) 8.5 ± 4.5, 1.9-25.9
History of Depression, n (%) 42 (56%)